Anonymous
Guest
Anonymous
Guest
Just saw the new study in the neurology journal looks great. If we have fighting chance against namenda decline how about you forest executive panty sniffers give us back the only study we have ever had that is worth a damn. I am sure the response will be to sell through it and while that is awesome advice and hopefully I can sell my soul one day to vomit the company rhetoric to dull sales reps we actually need a competitive advantage vs bringing in cookies to offices with our inflated budget.